False
By James Strachan
September 9, 2026
Why sample integrity, robust workflows, and operational rigor are as important as analytical innovation in translating complex biological data into better patient care
7 min read
September 3, 2026
How patient-derived tumor organoids, high-content screening, and advanced analytical readouts could provide more predictive models for cancer drug discovery
8 min read
By James Strachan
August 27, 2026
How complex biological models, larger datasets, and laboratory automation are shaping drug discovery decisions
3 min read
August 10, 2026
Mission Bio’s Mike Molnar explains how single-cell multiomics could improve vector copy number analysis, product characterization, and safety assessment in CAR T development
5 min read
By Katherine Tran
August 3, 2026
Immunopeptidomics is helping researchers identify tumor-presented antigens that could inform the development of targeted cell therapies and personalized cancer vaccines
3 min read
July 27, 2026
How advances in microarray technology are helping bring genomic data closer to real-time clinical decision-making
4 min read
By Christina Casén
July 20, 2026
Going beyond the gut: why microbiome testing is the next big thing in drug development
3 min read
July 2, 2026
This month’s analytical science business news: Merck’s Bio-Techne acquisition, plus major ASMS product launches
3 min read
June 15, 2026
Kelly Broster of Thermo Fisher Scientific explains why GLP-1 peptides are exposing the limits of traditional analytical workflows
6 min read
June 10, 2026
Antibody-drug conjugates are transforming cancer care, but their success depends on more precise, sensitive, and data-driven diagnostics
13 min read
False